Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sigma-Aldrich Corporation    SIAL   US8265521018

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/24/2014 10/27/2014 10/28/2014 10/29/2014 10/30/2014 Date
135.07(c) 134.9(c) 135.36(c) 134.91(c) 135.58 Last
725 770 1 030 345 874 866 1 873 647 719 648 Volume
-0.23% -0.13% +0.34% -0.33% +0.50% Change
More quotes
Company
Sigma-Aldrich Corp. operates as a life science and technology material company.It develops, manufactures, purchases and distributes a broad range of biochemical and organic chemicals.The company's biochemical and organic chemical products are used in scientific research, including genomic and... 
Sector
Specialty Chemicals
Calendar
11/26Ex-dividend day
Surperformance© rating of Sigma-Aldrich Corporation
Trading Rating : Investor Rating :
More about the company
Chart SIGMA-ALDRICH CORPORATION
Duration : Period :
Sigma-Aldrich Corporation Technical Analysis Chart | SIAL | US8265521018 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 784 M
EBIT 2014 718 M
Net income 2014 504 M
Debt 2014 275 M
Yield 2014 0,68%
Sales 2015 2 887 M
EBIT 2015 751 M
Net income 2015 552 M
Debt 2015 442 M
Yield 2015 0,70%
PER 2014 32,03
PER 2015 29,39
EV / Sales 2014 5,87x
EV / Sales 2015 5,72x
Capitalization 16 066 M
More Financials
Latest news on SIGMA-ALDRICH CORPORATION
1d ago SIGMA ALDRICH : SAFC Launches New Protein Quality Supplement to Increase N-linke..
3d ago Cell Isolation/Cell Separation Market Worth $5.1 Billion by 2019
10/23 SIGMA ALDRICH : Management's Discussion and Analysis of Financial Condition and ..
10/23 SIGMA ALDRICH : meets 3Q profit forecasts
10/23 SIGMA ALDRICH : Results of Operations and Financial Condition, Financial Stateme..
10/23 SIGMA ALDRICH : NASDAQ - SIAL) Reports Q3 2014 Results With Sales Of $690 Millio..
10/23 SIGMA ALDRICH : NASDAQ - SIAL) Reports Q3 2014 Results With Sales Of $690 Millio..
10/22 SIGMA ALDRICH : BioReliance® Introduces Advanced In Vitro ADME and Toxicology Se..
10/22 SIGMA ALDRICH : SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit I..
10/20SIGMA-ALDRICH CORPORATION : quaterly earnings release
10/20 SIGMA ALDRICH : BioReliance Introduces Advanced In Vitro ADME and Toxicology Ser..
10/16 SIGMA ALDRICH : BioReliance® Introduces Advanced In Vitro ADME and Toxicology Se..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF